Dark
Streaming/Mobile
Old Site
Home
Products
Help
Contact Us
Your Account
System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
07:07:25 EDT Sat 20 Apr 2024
Quotes
Streaming/Mobile
Quick Quotes (x20)
Symbol Search
Company Search
Market Depth
US Options
Montreal Options
Foreign Exchange
Download Close Prices
Short History
Quotes Help
Charts
12 Month Chart
Advanced Chart
Live Intraday Chart
Live Historical Chart
Live Java Intraday Chart
Live Java Historical Chart
Charts Help
News
News Search
SEDAR Search
SEDAR Alerts
News Help
Indexes
Major Indexes
US incl Dow Jones
NASDAQ
S&P CME
PBOT - Phil Ex
TSX - Toronto
TSX-V - TSX Venture
Indexes Help
Portfolio
View Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Value Portfolio
All Portfolios
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Edit Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Chart Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Live Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
View Portfolio News
Daily Summary
Portfolio Help
Analytics
Exchange Statistics
Most Active
Live Most Active
Block Trades
Broker Trades
Halted Stocks
Dividends
Participants
Companies
Trade Workstation
Company Picker
Short Positions
Broker Codes
Analytics Help
Mutual Funds
Mutual Fund Search
Targeted Holder Search
SEDAR Fund Search
Mutual Fund Help
Enter Symbol
or Name
USA
CA
Quote
Chart
News
Closes
Depth
Forgot password?
Trouble logging in?
Login to Stockwatch
Q:TLTFF
- THERALASE TECHNOLOGIES INC -
http://theralase.com
07:07:25 EDT
Sym-X
Bid - Ask
Last
Chg
%Ch
Vol
$Vol
#Tr
Open-Hi-Lo
Year Hi-Lo
Last Tr
News
Delay
TLTFF
- Q
not subscribed
0.1202
-0.0003
-0.2
4.0
0
4
0.1202
0.1202
0.1202
0.2357 0.1115
14:35:38
Apr 05
15 min
RT 2¢
Trade times are ET. News times are ET. Bid/ask/vol sizes in thousands.
OTC Markets Indicators -- Primary Market:
OTC Markets
-- Tier:
OTCQB
-- Status:
Active
Fundamentals
·
Holders
·
Trade Workstation
·
Market Depth
·
3 Month Closes
·
Technical Charts
1 yr
|
2 yr
|
3 yr
|
5 yr
|
10 yr
|
15 yr
|
20 yr
·
Live Charts
1 yr
|
1 day
·
1yr Bulletins
·
Historical
·
Portfolio
Recent Trades - All 4 today
More trades...
Time ET
Ex
Price
Change
Volume
14:35:38
Q
0.1202
-0.0003
500
14:35:38
Q
0.1202
-0.0003
500
14:35:38
Q
0.1202
-0.0003
1,000
14:35:38
Q
0.1202
-0.0003
2,000
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
Recent Bulletins
News Releases
In The News
Other
Date ET
Symbol
Type
Headline
2024-04-05 07:03
U:TLTFF
News Release
200
Theralase(R) Granted Canadian Cancer Vaccine Patent
2024-03-27 07:03
U:TLTFF
News Release
200
Theralase(R) Release's 4Q2023 Interim Financial Statements
2024-03-26 07:03
U:TLTFF
News Release
200
Theralase(R) to Host Advisory Board Meetings at Canadian Urological Association Bladder Cancer Forum and the American Urological Association
2024-02-12 07:02
U:TLTFF
News Release
200
Theralase(R) Donates Cool Laser Therapy Technology to Aid in Research and Development of a Treatment for Parkinson's Disease
2024-02-08 07:03
U:TLTFF
News Release
200
Dr. Michael Jewett Joins Theralase(R) to Help Complete Enrollment in the Phase II Non-Muscle Invasive Bladder Cancer Clinical Study
2024-02-05 16:36
U:TLTFF
News Release
200
Theralase(R) Closes $CAN 1.2 Million Non-Brokered Private Placement
2024-01-15 07:02
U:TLTFF
News Release
200
Theralase(R) Provides Update on Phase II Bladder Cancer Clinical Study
2023-11-29 18:31
U:TLTFF
News Release
200
Theralase Release ¢ € ™s 3Q2023 Interim Financial Statements
2023-11-29 16:37
U:TLTFF
News Release
200
Theralase(R) Closes $CAN 1.17 Million Non-Brokered Private Placement
2023-11-17 16:31
U:TLTFF
News Release
200
Theralase(R) Commences Non-Brokered Private Placement and Termination of Previously Announced Financing
2023-10-23 17:56
U:TLTFF
News Release
200
Theralase(R) Announces Brokered LIFE Financing
2023-10-23 07:01
U:TLTFF
News Release
200
Theralase(R) Optimizes Phase II Bladder Cancer Clinical Study
2023-10-16 07:03
U:TLTFF
News Release
200
Theralase(R) Provides Update on Bladder Cancer Clinical Study
2023-10-05 07:01
U:TLTFF
News Release
200
Theralase(R) Files US Patent for Enhanced Immunotherapy
2023-09-29 07:02
U:TLTFF
News Release
200
Theralase(R) Demonstrates 8 Year Shelf Life of Lead Drug Ruvidar(TM)
2023-09-27 07:02
U:TLTFF
News Release
200
Theralase(R) Successfully Completes Non-GLP Toxicity Analysis for Brain Cancer
2023-09-21 16:36
U:TLTFF
News Release
200
Theralase(R) Grants Stock Options
2023-09-07 16:31
U:TLTFF
News Release
200
Theralase(R) Closes Private Placement Equity Financing
2023-08-29 16:32
U:TLTFF
News Release
200
Theralase Release ¢ € ™s 2Q2023 Interim Financial Statements
2023-06-30 16:35
U:TLTFF
News Release
200
Theralase(R) Closes Non-Brokered Private Placement Equity Financing